Related Experiment Video
Updated: Jul 19, 2026
06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
[New therapies for autoimmune diseases]
1Service de Médecine Interne, Centre National de Référence Lupus et Syndrome des Anticorps Antiphospholipides, CHU Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75013 Paris. zahir.amoura@psl.aphp.fr
Revue Neurologique
|November 1, 2006
Summary
New biotherapies target key immune response steps for autoimmune diseases. These advanced treatments offer novel strategies for managing systemic autoimmune conditions.
Area of Science:
- Immunology
- Biotherapy
- Autoimmune Diseases
Context:
- Systemic autoimmune diseases have seen advancements in treatment strategies over the past decade.
- Understanding the immune response has paved the way for targeted biotherapies.
Purpose:
- To review novel biotherapies developed for systemic autoimmune diseases.
- To highlight therapeutic targets across the immune response pathway.
Summary:
- Biotherapies include B lymphocyte inhibitors (e.g., anti-CD20 monoclonal antibodies), costimulation inhibitors (e.g., anti-CD40 ligand antibodies, CTLA4-Ig), T lymphocyte antagonists, cytokine antagonists, and chemokine/adhesin antagonists.
- These therapies target various stages of the immune response, including B cell activity, cell-cell interactions, T cell proliferation, and immune cell trafficking.
Impact:
- These biotherapies represent a significant shift in managing autoimmune diseases.
- A deeper understanding of autoimmune mechanisms enables more precise and effective therapeutic interventions.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...